tirzepatide sales 2024 Weight-loss drug powers Lilly results, forecast raised by $3 billion Weight-loss drug drives Eli Lilly

SculptMED Aesthetics prioritizes transparency and customer satisfaction, ensuring that you receive personalized care tailored to your needs and goals

Side effects Most common: nausea, vomiting, diarrhea, constipation, decreased appetite, abdominal discomfort, fatigue, and injection-site reactions

Mounjaro was first approved by the FDA in May 2022 to treat type 2 diabetes, and Zepbound was approved by the FDA in November 2023 for long-term weight loss in adults with both obesity and either diabetes or an increased risk for a cardiovascular condition

Vitamin B12 is a water-soluble vitamin that the body needs in small amounts, ideally daily, to function properly

Bhanusali says, but he recommends them less frequently as they can be irritating

This plan specifies the type of GLP-1 medication (Semaglutide or Tirzepatide), starting dose, and any necessary adjustments over time